代谢与遗传标志物提高中国汉族人群2型糖尿病发病预测:巢式病例对照研究
在无锡非传染性疾病队列12年随访中,纳入220例新发2型糖尿病患者和220例年龄性别匹配的血糖正常对照。发现5种代谢物异常与未来2型糖尿病风险相关,基于20个SNP的遗传风险评分与风险显著相关(OR=1.35;95%CI 1.08-1.70每SD)。包含代谢物、遗传风险评分和临床特征的模型AUC优于仅含临床特征的模型(0.960 vs 0.798,P=7.91×10⁻¹⁶)。
要点
- 5种代谢物(核黄素、cnidioside A、2-甲氧基-5-(1H-1,2,4-三唑-5-基)-4-(三氟甲基)吡啶、7-甲基黄嘌呤、美雌醇)异常与未来2型糖尿病风险相关。
- 基于20个SNP的遗传风险评分与2型糖尿病风险显著相关(OR=1.35每SD;95%CI 1.08-1.70)。
- 代谢物+遗传风险评分+临床特征模型预测效能优于仅临床特征模型(AUC 0.960 vs 0.798,P=7.91×10⁻¹⁶)。
核心结论
- 在空腹血糖正常的汉族人群中,5种代谢物异常与未来2型糖尿病风险相关,代谢与遗传标志物联合可提高对2型糖尿病发病的预测。
研究设计与样本
- 在无锡非传染性疾病队列12年随访中开展巢式病例对照研究,纳入220例新发2型糖尿病患者和220例年龄、性别匹配的血糖正常汉族对照。
- 采用高效液相色谱-质谱联用(HPLC-MS)非靶向策略进行代谢谱检测,并使用Iplex Sequenom MassARRAY平台对20个与2型糖尿病相关的单核苷酸多态性(SNP)进行基因分型。
- 使用机器学习方法识别与未来2型糖尿病风险相关的代谢物。
主要发现
- 核黄素、cnidioside A、2-甲氧基-5-(1H-1,2,4-三唑-5-基)-4-(三氟甲基)吡啶、7-甲基黄嘌呤和美雌醇共5种代谢物水平异常与未来2型糖尿病风险升高相关。
- 基于20个SNP的遗传风险评分(GRS)与2型糖尿病风险显著相关(OR=1.35;95%CI 1.08-1.70每SD)。
- 包含代谢物、GRS和临床特征的模型AUC为0.960,优于仅含临床特征模型的0.798(P=7.91×10⁻¹⁶)。
关键数值与推荐
- 遗传风险评分基于20个SNP,每增加1个标准差,2型糖尿病风险OR=1.35(95%CI 1.08-1.70)。
- 包含代谢物、GRS和临床特征模型的AUC为0.960,仅含临床特征模型AUC为0.798(P=7.91×10⁻¹⁶)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: It is essential to improve the current predictive ability for type 2 diabetes (T2D) risk. OBJECTIVE: We aimed to identify novel metabolic markers for future T2D in Chinese individuals of Han ethnicity and to determine whether the combined effect of metabolic and genetic markers improves the accuracy of prediction models containing clinical factors. METHODS: A nested case-control study containing 220 incident T2D patients and 220 age- and sex- matched controls from normoglycemic Chinese individuals of Han ethnicity was conducted within the Wuxi Non-Communicable Disease cohort with a 12-year follow-up. Metabolic profiling detection was performed by high-performance liquid chromatography‒mass spectrometry (HPLC-MS) by an untargeted strategy and 20 single nucleotide polymorphisms (SNPs) associated with T2D were genotyped using the Iplex Sequenom MassARRAY platform. Machine learning methods were used to identify metabolites associated with future T2D risk. RESULTS: We found that abnormal levels of 5 metabolites were associated with increased risk of future T2D: riboflavin, cnidioside A, 2-methoxy-5-(1H-1, 2, 4-triazol-5-yl)- 4-(trifluoromethyl) pyridine, 7-methylxanthine, and mestranol. The genetic risk score (GRS) based on 20 SNPs was significantly associated with T2D risk (OR = 1.35; 95% CI, 1.08-1.70 per SD). The area under the receiver operating characteristic curve (AUC) was greater for the model containing metabolites, GRS, and clinical traits than for the model containing clinical traits only (0.960 vs 0.798, P = 7.91 × 10-16). CONCLUSION: In individuals with normal fasting glucose levels, abnormal levels of 5 metabolites were associated with future T2D. The combination of newly discovered metabolic markers and genetic markers could improve the prediction of incident T2D.
引用
- Liu J, Wang L, Qian Y, et al. Metabolic and Genetic Markers Improve Prediction of Incident Type 2 Diabetes: A Nested Case-Control Study in Chinese. J Clin Endocrinol Metab. 2022. PMID: 35977051. doi:10.1210/clinem/dgac487
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。